Mesirow Financial Investment Management - Fixed Income’s Emergent Biosolutions EBS Stock Holding History

Mesirow Financial Investment Management - Fixed Income’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,985	Closed	-$164K	–	127
2022 Q1	$164K	Sell	3,985 -85	-2%	-$3.75K	0.02%	124
2021 Q4	$177K	Buy	+4,070	New	+$184K	0.02%	130
2017 Q1	–	Sell	-486,609	Closed	-$16M	–	194
2016 Q4	$16M	Buy	486,609 +99,325	+26%	+$2.98M	0.98%	66
2016 Q3	$12.2M	Sell	387,284 -161,715	-29%	-$4.7M	0.72%	76
2016 Q2	$15.4M	Buy	+548,999	New	+$21.5M	0.9%	71

Other funds holding EBS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mesirow Financial Investment Management - Fixed Income's EBS Position: Q2 2022 in Review

Mesirow Financial Investment Management - Fixed Income sold out of Emergent Biosolutions (EBS) in Q2 2022, closing a stake of 3,985 shares — an estimated $164K sold.

Mesirow Financial Investment Management - Fixed Income first reported a position in EBS in Q2 2016 and held it in 5 quarters. The position peaked at $16M in Q4 2016. 232 funds tracked by Wall St. Rank hold EBS as of Q2 2022.

Mesirow Financial Investment Management - Fixed Income reported no remaining Emergent Biosolutions position as of Q2 2022 after selling out during the quarter.
Mesirow Financial Investment Management - Fixed Income sold 3,985 Emergent Biosolutions shares in Q2 2022, an estimated $164K.
Mesirow Financial Investment Management - Fixed Income first reported a position in Emergent Biosolutions in Q2 2016 and held it in 5 quarters.
Mesirow Financial Investment Management - Fixed Income's Emergent Biosolutions position peaked at $16M in Q4 2016.
232 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2022.

Based on Mesirow Financial Investment Management - Fixed Income's 13F filing for Q2 2022, filed 8 Aug 2022.